产品
编 号：F746586
分子式：C36H46N4O5
分子量：614.77
分子式：C36H46N4O5
分子量：614.77
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
结构图
CAS No: 1656261-09-4
产品详情
生物活性：
SCO-267 is an allosteric GPR40 full agonist. SCO-267 can be used for the research of chronic diseases including diabetes.
体内研究：
SCO-267 (1 or 10 mg/kg; p.o.) improves insulin sensitivity and exerts sustained glucose-lowering effect.Animal Model:N-STZ rats
Dosage:1 or 10 mg/kg
Administration:P.o.;
Result:Improved insulin sensitivity and exerted sustained glucose-lowering effect.
体外研究：
SCO-267 (CHO cells) activates the Gαq, Gαs, and Gα12/13 pathways and β-Arrestin Recruitment. SCO-267 is allosteric with fasiglifam and an endogenous ligand.
SCO-267 is an allosteric GPR40 full agonist. SCO-267 can be used for the research of chronic diseases including diabetes.
体内研究：
SCO-267 (1 or 10 mg/kg; p.o.) improves insulin sensitivity and exerts sustained glucose-lowering effect.Animal Model:N-STZ rats
Dosage:1 or 10 mg/kg
Administration:P.o.;
Result:Improved insulin sensitivity and exerted sustained glucose-lowering effect.
体外研究：
SCO-267 (CHO cells) activates the Gαq, Gαs, and Gα12/13 pathways and β-Arrestin Recruitment. SCO-267 is allosteric with fasiglifam and an endogenous ligand.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备